v3.26.1
Other Balance Sheet Components - Schedule of Accrued Liabilities (Details) - USD ($)
$ in Millions
Jun. 30, 2026
Dec. 31, 2025
Organization, Consolidation and Presentation of Financial Statements [Abstract]    
Royalties $ 954 $ 31
Provisions related to product sales (Note 3) 421 509
Compensation-related 192 420
Manufacturing 86 140
Development operations 78 106
Other external goods and services 58 57
Raw materials 44 30
Clinical trials 38 20
Property, plant and equipment 18 45
Commercial 18 23
Loss on future firm purchase commitments 2 5
Accrued liabilities $ 1,909 $ 1,386